Cargando…

Preclinical Evidence That 5-HT(1B) Receptor Agonists Show Promise as Medications for Psychostimulant Use Disorders

BACKGROUND: 5-HT(1B) receptor agonists enhance cocaine intake during daily self-administration sessions but decrease cocaine intake when tested after prolonged abstinence. We examined if 5-HT(1B) receptor agonists produce similar abstinence-dependent effects on methamphetamine intake. METHODS: Male...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia, Raul, Cotter, Austin R, Leslie, Kenneth, Olive, M Foster, Neisewander, Janet L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Regular Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570061/ https://www.ncbi.nlm.nih.gov/pubmed/28444326 http://dx.doi.org/10.1093/ijnp/pyx025

Ejemplares similares

Evidence base to support using prescribed psychostimulants to treat psychostimulant use disorder is limited
por: Bahji, Anees, et al.
Publicado: (2023)

The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans
por: Taylor, Sara B, et al.
Publicado: (2013)

Brain iron levels in attention-deficit/hyperactivity disorder normalize as a function of psychostimulant treatment duration
por: Adisetiyo, Vitria, et al.
Publicado: (2019)

Psychostimulants and Movement Disorders
por: Asser, Andres, et al.
Publicado: (2015)

5-HT(1B) receptor agonist enhances breakpoint for cocaine on a progressive ratio (PR) schedule during maintenance of self-administration in female rats but reduces breakpoint for sucrose
por: Scott, Samantha N., et al.
Publicado: (2022)

Translating the promise of 5HT(4) receptor agonists for the treatment of depression
por: Murphy, Susannah E, et al.
Publicado: (2021)

Preclinical support for the therapeutic potential of zolmitriptan as a treatment for cocaine use disorders
por: Garcia, Raul, et al.
Publicado: (2020)

Postsynaptic Mechanisms Render Syn I/II/III Mice Highly Responsive to Psychostimulants
por: Pogorelov, Vladimir M, et al.
Publicado: (2019)

Effects of a 5-HT(1B) Receptor Agonist on Locomotion and Reinstatement of Cocaine-Conditioned Place Preference after Abstinence from Repeated Injections in Mice
por: Der-Ghazarian, Taleen S., et al.
Publicado: (2017)

Addendum: Effects of a 5-HT(1B) Receptor Agonist on Locomotion and Reinstatement of Cocaine-Conditioned Place Preference after Abstinence from Repeated Injections in Mice
por: Der-Ghazarian, Taleen S., et al.
Publicado: (2018)

Psychostimulant Drugs and Neuroplasticity
por: Fernandez-Espejo, Emilio, et al.
Publicado: (2011)

New Approach to Combat Glioblastoma Shows Promise in Preclinical Studies
Publicado: (2006)

Interaction of Diamine Oxidase with Psychostimulant Drugs for ADHD Management
por: Tobajas, Yaiza, et al.
Publicado: (2023)

Neuroimmune Mechanisms as Novel Treatment Targets for Substance Use Disorders and Associated Comorbidities
por: Namba, Mark D., et al.
Publicado: (2021)

Risk of Tics with Psychostimulants for ADHD
por: Millichap, J. Gordon
Publicado: (2015)

Binge eating and psychostimulant addiction
por: Blanco-Gandia, M Carmen, et al.
Publicado: (2021)

Role of Microglia in Psychostimulant Addiction
por: Machado da Silva, Maria Carolina, et al.
Publicado: (2023)

In Vitro ADME and Preclinical Pharmacokinetics of Ulotaront, a TAAR1/5-HT(1A) Receptor Agonist for the Treatment of Schizophrenia
por: Xiao, Guangqing, et al.
Publicado: (2022)

Multimodal imaging study of the 5-HT(1A) receptor biased agonist, NLX-112, in a model of L-DOPA-induced dyskinesia
por: Chaib, Sarah, et al.
Publicado: (2023)

Pitolisant, a wake‐promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol
por: Krief, Stéphane, et al.
Publicado: (2021)

5-HT(1A) Agonist Properties Contribute to a Robust Response to Vilazodone in the Novelty Suppressed Feeding Paradigm
por: Garcia-Garcia, Alvaro L., et al.
Publicado: (2016)

A mechanistic overview of approaches for the treatment of psychostimulant dependence
por: Jensen, Kathrine Louise, et al.
Publicado: (2022)

Preclinical evaluation of marketed sodium channel blockers in a rat model of myotonia discloses promising antimyotonic drugs
por: Desaphy, Jean-François, et al.
Publicado: (2014)

Pharmacophore Directed Screening of Agonistic Natural Molecules Showing Affinity to 5HT(2C) Receptor
por: Veeramachaneni, Ganesh Kumar, et al.
Publicado: (2019)

Pharmacological Evidence for an Abstinence-Induced Switch in 5-HT(1B) Receptor Modulation of Cocaine Self-Administration and Cocaine-Seeking Behavior
por: Pentkowski, Nathan S., et al.
Publicado: (2013)

The Role of Adenosine Receptors in Psychostimulant Addiction
por: Ballesteros-Yáñez, Inmaculada, et al.
Publicado: (2018)

The Use of Drosophila to Understand Psychostimulant Responses
por: Philyaw, Travis James, et al.
Publicado: (2022)

The role of serotoninergic system in psychostimulant effects
por: Taracha, Ewa
Publicado: (2021)

Dysfunction of the Neurovascular Unit by Psychostimulant Drugs
por: Vo, Tam Thuy Lu, et al.
Publicado: (2023)

The Therapeutic Potential of Amphetamine-like Psychostimulants
por: Pires, Bruno, et al.
Publicado: (2023)

Activating p53 in Cancer Cells with Protein Therapy Shows Preclinical Promise
Publicado: (2004)

A re-engineered immunotoxin shows promising preclinical activity in ovarian cancer
por: Kollmorgen, Gwendlyn, et al.
Publicado: (2017)

Radiosynthesis and preclinical evaluation of [(11)C]prucalopride as a potential agonist PET ligand for the 5-HT(4) receptor
por: Buiter, Hans JC, et al.
Publicado: (2013)

Behavioral effects of ketamine and toxic interactions with psychostimulants
por: Hayase, Tamaki, et al.
Publicado: (2006)

Is there potential for the treatment of children with ADHD beyond psychostimulants?
por: Hoekstra, Pieter J.
Publicado: (2011)

The Health Effect of Psychostimulants: A Literature Review
por: Favrod-Coune, Thierry, et al.
Publicado: (2010)

Ghrelin and ghrelin receptor modulation of psychostimulant action
por: Wellman, Paul J., et al.
Publicado: (2013)

The Involvement of Norepinephrine in Behaviors Related to Psychostimulant Addiction
por: Zaniewska, Magdalena, et al.
Publicado: (2015)

Role of nitric oxide in psychostimulant-induced neurotoxicity
por: Bashkatova, Valentina, et al.
Publicado: (2019)

S95. DIFFERENCES IN LIFETIME PATTERNS OF PSYCHOSTIMULANTS AND THEIR IMPACT ON THE PROPORTION OF PATIENTS WITH FIRST-EPISODE PSYCHOSIS ATTRIBUTABLE TO PSYCHOSTIMULANTS USE ACROSS EUROPE
por: Duran-Cutilla, Manuel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_num132jp1gcc7bu23mgkl3s53j